Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.
Ingrid HokstadGia DeyabMorten Wang FagerlandTorstein LybergGunnbjørg HjeltnesØystein FørreStefan AgewallTom Eirik MollnesIvana HollanPublished in: PloS one (2019)
Clinical Trials (NCT00902005), retrospectively registered on the 14th of May 2009.